Infections in Ichthyosis: A Call for Vigilance

Patients with ALOX12B-associated autosomal recessive congenital ichthyosis face significant infectious risks beyond the skin. Clinicians should adopt proactive surveillance and management strategies, including early broad-spectrum antibiotics, to mitigate life-threatening complications.

Does Vitamin D Improve Outcomes in Orthopedic Trauma?

For patients with orthopedic trauma, the question remains whether Vitamin D supplementation truly accelerates fracture healing or reduces infection risk. Existing evidence is plagued by heterogeneity and methodological weaknesses, making definitive recommendations premature.

Lorlatinib and the Enigma of Autoantibody-Negative Diabetes

Patients on lorlatinib may develop diabetes with unusual characteristics, including the absence of typical autoantibodies. This presents a diagnostic challenge, requiring clinicians to consider drug-induced etiologies even when initial immunological markers are negative.

A Systemic Approach to Atopic Dermatitis Treatment Selection

Systemic therapies for atopic dermatitis require careful patient selection and monitoring to maximize benefit and minimize risk. This case highlights the importance of considering disease severity, patient comorbidities, and prior treatment responses when choosing advanced therapies like biologics or small molecule inhibitors.

Lorlatinib and Diabetic Ketoacidosis An Emerging Class Effect?

Patients on lorlatinib should be monitored for hyperglycemia, regardless of autoantibody status. This case raises concerns about potential metabolic toxicities of ALK inhibitors beyond what is currently recognized.